These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 10572396
1. [The role of monocyte chemotactic and activating factor (MCAF)/monocyte chemoattractant protein (MCP)-1 in subgroups of rapidly progressive glomerulonephritis]. Sakai N, Wada T, Furuichi K, Takaeda C, Shimizu M, Iwata Y, Yoshimoto K, Shimizu K, Kobayashi K, Takeda S, Kida H, Mukaida N, Matsushima K, Yokoyama H. Nihon Jinzo Gakkai Shi; 1999 Oct; 41(7):704-11. PubMed ID: 10572396 [Abstract] [Full Text] [Related]
2. MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Wada T, Furuichi K, Segawa-Takaeda C, Shimizu M, Sakai N, Takeda SI, Takasawa K, Kida H, Kobayashi KI, Mukaida N, Ohmoto Y, Matsushima K, Yokoyama H. Kidney Int; 1999 Sep; 56(3):995-1003. PubMed ID: 10469367 [Abstract] [Full Text] [Related]
3. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis. Tang Z, Zhou H, Yao X, Hu W, Leishi L. Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342 [Abstract] [Full Text] [Related]
4. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). Wada T, Yokoyama H, Furuichi K, Kobayashi KI, Harada K, Naruto M, Su SB, Akiyama M, Mukaida N, Matsushima K. FASEB J; 1996 Oct; 10(12):1418-25. PubMed ID: 8903512 [Abstract] [Full Text] [Related]
5. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Tam FW, Sanders JS, George A, Hammad T, Miller C, Dougan T, Cook HT, Kallenberg CG, Gaskin G, Levy JB, Pusey CD. Nephrol Dial Transplant; 2004 Nov; 19(11):2761-8. PubMed ID: 15353578 [Abstract] [Full Text] [Related]
6. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. Matsumori A, Furukawa Y, Hashimoto T, Yoshida A, Ono K, Shioi T, Okada M, Iwasaki A, Nishio R, Matsushima K, Sasayama S. J Mol Cell Cardiol; 1997 Jan; 29(1):419-23. PubMed ID: 9040055 [Abstract] [Full Text] [Related]
7. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection. Prodjosudjadi W, Daha MR, Gerritsma JS, Florijn KW, Barendregt JN, Bruijn JA, van der Woude FJ, van Es LA. Nephrol Dial Transplant; 1996 Jun; 11(6):1096-103. PubMed ID: 8671975 [Abstract] [Full Text] [Related]
8. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Wada T, Yokoyama H, Su SB, Mukaida N, Iwano M, Dohi K, Takahashi Y, Sasaki T, Furuichi K, Segawa C, Hisada Y, Ohta S, Takasawa K, Kobayashi K, Matsushima K. Kidney Int; 1996 Mar; 49(3):761-7. PubMed ID: 8648917 [Abstract] [Full Text] [Related]
9. Monocyte chemotactic and activating factor/monocyte chemoattractant protein (MCAF/MCP-1) in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis. Jahnz-Rózyk KM, Kuna P, Pirozyńska E. J Investig Allergol Clin Immunol; 1997 Mar; 7(4):254-9. PubMed ID: 9330191 [Abstract] [Full Text] [Related]
10. Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Ono K, Matsumori A, Furukawa Y, Igata H, Shioi T, Matsushima K, Sasayama S. Lab Invest; 1999 Feb; 79(2):195-203. PubMed ID: 10068207 [Abstract] [Full Text] [Related]
11. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Noris M, Bernasconi S, Casiraghi F, Sozzani S, Gotti E, Remuzzi G, Mantovani A. Lab Invest; 1995 Dec; 73(6):804-9. PubMed ID: 8558841 [Abstract] [Full Text] [Related]
12. [Steroid pulse therapy in rapidly progressive glomerulonephritis]. Ogi M, Yoshimura M, Ikeda K, Saito Y, Kida H, Sugioka G, Watanabe K. Nihon Jinzo Gakkai Shi; 1992 Jun; 34(6):669-75. PubMed ID: 1479706 [Abstract] [Full Text] [Related]
13. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis. Liu ZH, Chen SF, Zhou H, Chen HP, Li LS. Nephrol Dial Transplant; 2003 Aug; 18(8):1526-34. PubMed ID: 12897090 [Abstract] [Full Text] [Related]
14. Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Kimura H, Kasahara Y, Kurosu K, Sugito K, Takiguchi Y, Terai M, Mikata A, Natsume M, Mukaida N, Matsushima K, Kuriyama T. Lab Invest; 1998 May; 78(5):571-81. PubMed ID: 9605182 [Abstract] [Full Text] [Related]
15. Urinary levels of chemokines (MCAF/MCP-1, IL-8) reflect distinct disease activities and phases of human IgA nephropathy. Yokoyama H, Wada T, Furuichi K, Segawa C, Shimizu M, Kobayashi K, Su S, Mukaida N, Matsushima K. J Leukoc Biol; 1998 Apr; 63(4):493-9. PubMed ID: 9544580 [Abstract] [Full Text] [Related]
16. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Viksman MY, Kaplan AP. J Immunol; 1992 Jul 15; 149(2):636-42. PubMed ID: 1378073 [Abstract] [Full Text] [Related]
17. Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulo-interstitial lesions in patients with lupus nephritis. Dai C, Liu Z, Zhou H, Li L. Chin Med J (Engl); 2001 Aug 15; 114(8):864-8. PubMed ID: 11780369 [Abstract] [Full Text] [Related]
18. Potential role for monocyte chemotactic protein-4 (MCP-4) in monocyte/macrophage recruitment in acute renal inflammation. Chakravorty SJ, Howie AJ, Girdlestone J, Gentle D, Savage CO. J Pathol; 2001 Jun 15; 194(2):239-46. PubMed ID: 11400154 [Abstract] [Full Text] [Related]
19. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis. Wagrowska-Danilewicz M, Stasikowska O, Danilewicz M. Pol J Pathol; 2005 Jun 15; 56(3):115-20. PubMed ID: 16334978 [Abstract] [Full Text] [Related]
20. [Effects of methylprednisolone pulse therapy in the insidious type of crescentic glomerulonephritis]. Takeda S, Kida H, Takazakura E, Yokoyama H, Kobayashi K. Nihon Jinzo Gakkai Shi; 1997 Jul 15; 39(5):490-6. PubMed ID: 9379560 [Abstract] [Full Text] [Related] Page: [Next] [New Search]